SCHEMBL31464019

SCHEMBL31464019

CCOc1cccc(F)c1CN1CCN(C(=O)[C@H](N)C2CCN(CCc3cc(Cl)ccc3-c3ccccc3)CC2)CC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.39
ALOX15 P16050 2/20 0.39
TDP1 Q9NUW8 1/20 0.39
KDM4E B2RXH2 4/20 0.38
POLB P06746 2/20 0.38
TSHR P16473 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
HTR7 P34969 4/20 0.38
HTR1A P08908 3/20 0.38
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
CD274 Q9NZQ7 2/20 0.36
DRD2 P14416 2/20 0.36
DRD4 P21917 2/20 0.36
MC4R P32245 3/20 0.36
DPP8 Q6V1X1 1/20 0.35
MAPK1 P28482 1/20 0.35
LMNA P02545 1/20 0.35
MC5R P33032 1/20 0.35
MC3R P41968 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL27139895 0.99 ALDH1A1 (0.39) ALDH1A1ALOX15TDP1KDM4EPOLB
Hydrochloric Acid SCHEMBL31464067 0.99 ALDH1A1 (0.39) ALDH1A1ALOX15TDP1KDM4EPOLB
Hydrochloric Acid SCHEMBL27139892 0.99 ALDH1A1 (0.39) ALDH1A1ALOX15TDP1KDM4EPOLB
SCHEMBL31709148 0.96 ALDH1A1 (0.40) ALDH1A1ALOX15TDP1KDM4EPOLB
SCHEMBL31708935 0.96 ALDH1A1 (0.39) ALDH1A1ALOX15TDP1KDM4EPOLB
SCHEMBL31709133 0.96 ALDH1A1 (0.39) ALDH1A1ALOX15TDP1KDM4EPOLB
SCHEMBL31709068 0.94 ALDH1A1 (0.38) ALDH1A1ALOX15TDP1KDM4EPOLB
SCHEMBL31709242 0.94 ALDH1A1 (0.38) ALDH1A1ALOX15TDP1KDM4EPOLB
SCHEMBL31709108 0.94 ALDH1A1 (0.40) ALDH1A1ALOX15TDP1KDM4EPOLB
SCHEMBL31708808 0.94 ALDH1A1 (0.38) ALDH1A1ALOX15TDP1KDM4EPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250326744-A1 PIPERAZINE DERIVATIVE OR SALT THEREOF, AND PHARMACEUTICAL COMPOSITION FUJIFILM CORPORATION (JP) 2025-10-23 US claimed
CN-119816484-A Novel piperazine derivative or salt thereof and pharmaceutical composition 富士胶片株式会社 2025-04-11 CN claimed
US-20250326744-A1 PIPERAZINE DERIVATIVE OR SALT THEREOF, AND PHARMACEUTICAL COMPOSITION FUJIFILM CORPORATION (JP) 2025-10-23 US disclosed
CN-119816484-A Novel piperazine derivative or salt thereof and pharmaceutical composition 富士胶片株式会社 2025-04-11 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250326744-A1 PIPERAZINE DERIVATIVE OR SALT THEREOF, AND PHARMACEUTICAL COMPOSITION ABCB11, ABCC1, SLC11A2 ALDH1A1 774/4885ALOX15 1853/4885TDP1 4092/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.